Related Experiment Video
Updated: Sep 6, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Optimal molecular selection to benefit from nivolumab-ipilimumab in clear-cell renal cell carcinoma
Yann-Alexandre Vano1, Réza Elaidi2, Letuan Phan2
1Department of Medical Oncology, Hoôpital Europeéen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP Centre-Université Paris Cité, 75015 Paris, France (Y-AV, SO); Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, F-75006, Paris, France; INSERM U970, PARCC, 75015 Paris, France.
No abstract available in PubMed .
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...